About Boston Genetics
Boston Genetics is a Healthcare company based in Cambridge (United States) founded in 2019, and was acquired by Genomenon in June 2023. Gene therapy-based drug development services are provided. Its focus areas include Biopharma Outsourcing, Diversified and Cell & Gene Therapy. Its competitors include Blue Rock Therapeutics, Ascend and Impel Pharmaceuticals; 3 of its 3 listed competitors have raised funding.
Company details
Boston Genetics was established in 2019 in Cambridge, United States, within the biotechnology sector. Focus is placed on gene therapy-based drug development services, where preclinical and clinical support are offered to clients. Operations center on advancing therapeutic innovations through genetic approaches. Expertise is applied in areas such as vector design and regulatory compliance, serving pharmaceutical partners across the region. The companys domain, bostongen.com, facilitates client interactions and resource access.
- Headquarters Cambridge, United States
- Stage Acquired
- SectorsHealthcare
- Website bostongen.com
- Acquired by Genomenon (Jun 2023)
Investors in Boston Genetics
Boston Genetics has secured backing from 1 investor. Prominent investors backing the company include Genomenon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AI-based bioinformatics tools and genomic variants meta-database are developed. | 2014 | genomenon.com | Ann Arbor, United States |
Investor details for Boston Genetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Boston Genetics
2 dated milestones of Boston Genetics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Boston Genetics is founded.
- Exit Acquired by Genomenon.
Competitors of Boston Genetics
Boston Genetics has 3 listed competitors in our database, 3 of them funded. They include Blue Rock Therapeutics, Ascend and Impel Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bluerocktx.com | 2016 | Boston, United States | $225M | 138 | Stem cell therapies are developed for cardiovascular and neurological diseases. | |
| useascend.com | 2021 | Palo Alto, United States | $35.5M | 39 | Online insurance payments and premium financing are enabled for businesses. | |
| impelpharma.com | 2008 | Seattle, United States | $67.5M | Transformative therapies are developed and commercialized through specialized services. |
Detailed competitors of Boston Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Boston Genetics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Boston Genetics
Complete news archive for Boston Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boston Genetics
Boston Genetics was founded in 2019.
Boston Genetics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Boston Genetics was established in 2019 in Cambridge, United States, within the biotechnology sector. Focus is placed on gene therapy-based drug development services, where preclinical and clinical support are offered to clients. Operations center on advancing therapeutic innovations through genetic approaches. Expertise is applied in areas such as vector design and regulatory compliance, serving pharmaceutical partners across the region. The companys domain, bostongen.com, facilitates client interactions and resource access.
Boston Genetics's top competitors include Blue Rock Therapeutics, Ascend and Impel Pharmaceuticals.
Boston Genetics has 1 investor. Key investors include Genomenon.
Yes. Boston Genetics was acquired by Genomenon in June 2023.